Research On Social Responsibility Report Of Listed Companies In Pharmaceutical Industry

With the gradual deepening of the world's sustainable development theory,enterprises are increasingly aware that the era of focusing on economic interests has gradually drifted away,and more and more companies will promote social and environmental changes as their own goals.At the same time,awareness of social responsibility has soared among enterprises.In recent years,although the number of social responsibility reports has increased significantly,the quality is still worrying.However,the public has put forward more requirements on whether or not companies should assume and how to shoulder social responsibilities.Under the guidance of the concept of scientific development,China has successively issued a number of documents to regulate issues related to the issuance of social responsibility reports.The number of listed companies that publish social responsibility reports in China continues to increase,but overall,there is still room for improvement in the quality of current reports.The pharmaceutical industry has been highly valued by all sectors of society because of its characteristics of high investment,high risk,high technology,and relevant to people's livelihood.The fulfillment of social responsibility in the pharmaceutical industry has also become a topic of common concern in the society.Therefore,this article selects Jilin.The disclosure of the corporate social responsibility report of Dongfang Pharmaceutical Co.,Ltd.is used as a sample to study the current situation of China's pharmaceutical industry social responsibility report.This article is divided into six parts:Part I,introduction.It mainly introduces the background and significance of the research,domestic and foreign research related research,and the content and methods of this article.The second part summarizes related theories,collates and summarizes relevant theories of corporate social responsibility report;the third part,listed companies in the pharmaceutical industry.The fourth part summarizes the status qua of Jilin Jidong Pharmaceutical Corporation's social responsibility report disclosure;the fifth part,according to the above analysis and research,discovers the existing problems of China's pharmaceutical industry social responsibility report and puts forward suggestions for improvement.The last part is the conclusion.The innovation of this article lies in keeping abreast with this new topic of social responsibility and conducting research on social responsibility issues that companies are paying more and more attention to.The inadequacy lies in the fact that the development of corporate social responsibility report in China is still in its infancy,and there are still no clear conclusions for many theories.This article only looks at the research of domestic and foreign scholars,and it needs to be improved in the future.I hope this article will contribute to the development of China's pharmaceutical industry's social responsibility report.